Latham & Watkins LLP represented the initial purchasers in the offering . Snap Inc., a camera and social media company, executed its US$1 billion aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Growth Street Partners on the deal. Growth Street Partners announced its minority growth equity investment in PikMyKid. Growth Street Partners provides early growth...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters. Vaccitech (Nasdaq: VACC) announced its initial public offering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vivid Money on the deal. Vivid Money announced its $73 million Series B funding round led by Greenoaks Capital, with participation from existing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Caresyntax on the deal. Caresyntax announced the completion of its $100 million Series C funding round led by PFM Health Sciences LP, and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Agusto Niz-Chavez on the deal. Mr. Niz-Chavez is a Guatemalan national who is the primary caretaker and breadwinner for his three young,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Agusto Niz-Chavez on the deal. Mr. Niz-Chavez is a Guatemalan national who is the primary caretaker and breadwinner for his three young,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Levine Leichtman Capital Partners on the deal. Levine Leichtman Capital Partners announced its investment in Prime Global Medical Communications Ltd. in partnership with...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and...
You must be a Standard 1 Year member to access this content.
